A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)

NCT05786573 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

DRUG: Obexelimab
DRUG: Obexelimab
OTHER: Placebo

Sponsor

Zenas BioPharma (USA), LLC